德国前卫生部长卡尔·劳特巴赫表示，在十年内治愈癌症、阿尔茨海默症和精神疾病是不可能的。他是在回应达里奥·阿莫代伊，后者所在公司的首次公开募股（IPO）路演视频称，这些疾病将在十年内成为“过去的遗物”。
Germany’s former health minister Karl Lauterbach has said that curing cancer, Alzheimer’s and mental illness within ten years is impossible. He was answering Dario Amodei, whose company’s IPO roadshow video says those diseases will be “relics of the past” within a decade.
据《商业内幕》11月11日报道，医生和一位生物技术高管也提出了反驳。在Anthropic寻求投资者、准备上市之际，特鲁曼·迪克森收集了这些反应。阿莫代伊对投资者说了什么Anthropic于11月10日开始通过路演视频推销其股份。视频中，公司首席执行官阿莫代伊点名了四种疾病。
Doctors and a biotech executive have pushed back too, Business Insider reported on 11 November. Truman Dickerson gathered the reactions as Anthropic courts investors ahead of its listing. What Amodei told investors Anthropic began marketing its shares on 10 November with a roadshow video. In it, Amodei, the company’s chief executive, named four diseases.
“如果我们今天看癌症、阿尔茨海默症、心脏病、精神疾病这些情况，我认为在不到十年的时间里，它们将成为过去的遗物，”阿莫代伊说。
“You know, if today we look at things like cancer, Alzheimer’s, heart disease, mental illness, these will be relics of the past in, I think, less than a decade,” Amodei said.
他补充道：“我认为如果我们做得对，我们可以创造一个奇迹时代，人类能够解决困扰我们数千年的问题。”
“I think if we do this right, we can create an age of miracles where humanity is able to solve problems that have eluded us for millennia,” he added.
他将这一承诺与安全性联系起来。他说，能够正确应对风险的公司将拥有“社会信任的经营许可”。治愈“触手可及”七位联合创始人在给投资者的信中阐述了医学论据，该信随最初的IPO申报文件首次公开。他们写道，人工智能能“让主要疾病的治愈触手可及”。
He tied the promise to safety. The company that gets the risks right will have “the license to operate that society trusts,” he said. Cures “within reach”The seven co-founders made the medical case in their letter to investors, first published with the original IPO filing. AI could “bring cures for major diseases within reach,” they wrote.
信中称：“首先，我们相信人工智能将深刻加速生物学和医学的进步速度，有可能治愈困扰人类数千年的疾病，包括癌症、阿尔茨海默病、心脏病、罕见遗传病和主要传染病。”
“First, we believe that AI will profoundly accelerate the rate of progress in biology and medicine, potentially curing diseases that have plagued humanity for millennia, including cancer, Alzheimer’s disease, heart disease, rare genetic diseases, and the major infectious diseases,” the letter says.
信中称，Anthropic 已与制药公司合作，涉及从药物发现到临床试验等任务。信中表示，其工作可将撰写临床试验报告的时间“从数月缩短至数分钟”。信中还列举了其他例子。世界卫生组织非洲区域办事处在 2026 年刚果民主共和国埃博拉疫情期间使用了 Claude。创始人写道，编制每日疫情报告的时间从整整一天缩短至不足一小时。
Anthropic already works with pharmaceutical companies on tasks from drug discovery to clinical trials, the letter says. It says its work can cut the time to write clinical trial reports “from months to minutes.”The letter gives other examples. The World Health Organization’s Regional Office for Africa used Claude during the 2026 Ebola outbreak in the Democratic Republic of the Congo. Preparing its daily situation report fell from a full day to under an hour, the founders wrote.
Anthropic 与盖茨基金会合作，为大约 100 个低收入和中等收入国家的医生提供免费 AI 临床搜索。创始人还写道，Anthropic 发现了一种分子机器，可能成为一种新的生物技术工具，或许可用于基因编辑。
With the Gates Foundation, Anthropic supports free AI clinical search for doctors in roughly 100 low- and middle-income countries. The founders also wrote that Anthropic has discovered a molecular machine that might become a new biotechnology tool, perhaps for gene editing.
信中援引世卫组织和世界银行的数据称，约 46 亿人仍无法获得基本卫生服务。创始人写道，AI 可以帮助将治疗手段带到最需要的地方。
About 4.6 billion people still lack access to essential health services, the letter says, citing the WHO and the World Bank. AI can help get treatments to where they are most needed, the founders wrote.
同一封信将“不过度承诺、交付超预期”列为 Anthropic 的指导原则之一。“不可能仅在 10 年内实现”作为医生和流行病学家的劳特巴赫于 11 月 11 日用德语在 X 上回复。
The same letter lists “underpromise and overdeliver” among Anthropic’s guiding principles. “Impossible in just 10 years”Lauterbach, a doctor and epidemiologist, answered in German on X on 11 November.
他写道：“不清楚 @DarioAmodei 这类人是对医学知之甚少，还是故意误导公众。治愈癌症、阿尔茨海默病和精神疾病肯定能从 AI 中受益。但绝不可能仅在 10 年内实现”（由 TNW 翻译）。他补充说，重点应放在预防上。
“It is unclear whether people like @DarioAmodei know so little about medicine or are deliberately misleading the public. Curing cancer, Alzheimer’s and mental illness can definitely benefit from AI. But it cannot possibly happen in just 10 years,” Lauterbach wrote (translated by TNW). He added that the focus should be on prevention.
据《商业内幕》报道，圣路易斯大学 AI 医学研究员兼医生 Melinda B. Chu 也对该说法提出质疑。
Melinda B. Chu, an AI medical researcher and doctor at Saint Louis University, also questioned the claim, according to Business Insider.
Chu 表示：“Anthropic 并未做出任何表明其自身将对这些目标做出实质性贡献的举动。”
“Anthropic has done nothing to suggest they themselves will contribute meaningfully to these goals,” Chu said.
生物技术高管 Rami Elghandour 指出了该说法提出的场合。
Rami Elghandour, a biotech executive, pointed to the setting of the claim.
据《商业内幕》报道，Elghandour 说：“我带过两家公司上市。在 IPO 路演中说出这种疯狂的话。”
“I’ve taken two companies public. These are insane things to say in an IPO pitch,” Elghandour said, according to Business Insider.
Amodei本人也对这种承诺提出了质疑。他在八月的 X 帖子中写道：“说 AI 能治愈癌症更像是陈词滥调，而不是鼓舞人心，大多数人认为这具有欺骗性。” Business Insider 报道，他写道，赢得怀疑者的最佳方式是“真正治愈癌症”。Anthropic 的实验室工作Anthropic 已开始开展自己的生物学工作。十月，它收购了一家专注于肌营养不良症的单人生物技术初创公司。根据 Business Insider 的报道，它已收购了多家生物技术初创公司。
Amodei has questioned this kind of promise himself. In an X post in August, he wrote that “saying that AI will cure cancer is more a cliché than it is inspiring, and most people think it is deceptive.”The best way to win over sceptics was to “actually cure cancer,” he wrote, as Business Insider noted. Anthropic’s own lab work Anthropic has started building its own biology work. In October, it bought a one-person biotech start-up working on muscular dystrophy. It has bought several biotech start-ups, according to Business Insider.
Anthropic 在十月的博客文章中表示，它已“开始自行进行药物发现工作”，Business Insider 报道。该公司还援引一位熟悉情况的人士称，Anthropic 在旧金山湾区设有湿实验室。
Anthropic said in an October blog post that it had “begun drug discovery efforts of our own,” Business Insider noted. It also reported, citing a person familiar, that Anthropic runs a wet lab in the Bay Area.
信中称，Anthropic 将与合作伙伴共同验证其预计 Claude 将取得的发现。创始人写道，其至少占公司股份 5% 的公共利益基金也可能用于科学、医学和全球健康。
The letter says Anthropic will work with partners to validate the discoveries it expects Claude to make. Its public benefit fund of at least 5% of its shares could also go to science, medicine and global health, the founders wrote.
Anthropic 的首次公开募股目标估值为 1.4 万亿美元。其股票计划于 11 月 19 日在纳斯达克开始交易。
Anthropic’s IPO seeks a $1.4 trillion valuation. Its shares are due to start trading on Nasdaq on 19 November.